Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States-Reference-Cited by-同舟云学术

Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States

Published:2016-11-22 Issue:2 Volume:57 Page:289-295
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Pine Alexander B.¹,Lee Eun-Ju²,Sekeres Mikkael³,Steensma David P.⁴,Zelterman Daniel⁵,Prebet Thomas²,DeZern Amy⁶,Komrokji Rami⁷,Litzow Mark⁸,Luger Selina⁹,Stone Richard⁴,Erba Harry P.¹⁰,Garcia-Manero Guillermo¹¹,Lee Alfred I.²,Podoltsev Nikolai A.²,Barbarotta Lisa¹,Kasberg Stephanie¹,Hendrickson Jeanne E.¹²,Gore Steven D.²,Zeidan Amer M.²

Affiliation:

1. Yale New Haven Hospital, Yale University School of Medicine; New Haven Connecticut

2. Department of Internal Medicine; Section of Hematology, Yale University School of Medicine; New Haven Connecticut

3. Leukemia Program; Cleveland Clinic; Cleveland Ohio

4. Dana-Farber Cancer Institute; Boston Massachusetts

5. Yale University School of Public Health; New Haven Connecticut

6. The Johns Hopkins School of Medicine; Baltimore Maryland

7. Department of Malignant Hematology; H. Lee Moffitt Cancer Center; Tampa Florida

8. Mayo Clinic; Rochester Minnesota

9. Abramson Cancer Center; University of Pennsylvania; Philadelphia Pennsylvania

10. University of Alabama; Birmingham Alabama

11. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

12. Department of Laboratory Medicine; Yale University School of Medicine; New Haven Connecticut

Funder

Public Health Service

National Cancer Institute

National Institutes of Health

Department of Health and Human Services

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13934/fullpdf

Reference19 articles.

1. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia;Rebulla;N Engl J Med,1997

2. A no-prophylaxis platelet-transfusion strategy for hematologic cancers;Stanworth;N Engl J Med,2013

3. Platelet transfusion: a clinical practice guideline from the AABB;Kaufman;Ann Intern Med,2015

4. Incidence and transfusion risk factors for transfusion-associated circulatory overload among medical intensive care unit patients;Li;Transfusion,2011

5. Transfusion-related acute lung injury: incidence and risk factors;Toy;Blood,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients;Transfusion Medicine and Hemotherapy;2023

2. Multi‐national survey of transfusion experiences and preferences of patients with myelodysplastic syndrome;Transfusion;2022-06-10

3. Racial differences in red blood cell transfusion in hospitalized patients with anemia;Transfusion;2022-06-03

4. Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights;Expert Review of Hematology;2022-05-04

5. The impact of pathogen‐reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trial;Transfusion Medicine;2022-01-12